AbCellera Biologics Inc. ABCL Available for sale investments
Available for sale investments at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s available for sale investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s available for sale investments?
- AbCellera Biologics Inc. (ABCL) reported available for sale investments of $427.67M in Q1 2026.
- How has AbCellera Biologics Inc.'s available for sale investments changed year-over-year?
- AbCellera Biologics Inc.'s available for sale investments decreased by 4.1% year-over-year, from $446M to $427.67M.
- What is the long-term trend for AbCellera Biologics Inc.'s available for sale investments?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s available for sale investments has grown at a 13.2% compound annual growth rate (CAGR), from $246.84M to $405.31M.